XM does not provide services to residents of the United States of America.
A
A

Apple

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

S&P 500, Nasdaq futures hover near record highs ahead of retail sales data

US STOCKS-S&P 500, Nasdaq futures hover near record highs ahead of retail sales data For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window Futures: Dow down 0.01%, S&P 500 up 0.03%, Nasdaq up 0.19% June 18 (Reuters) - U.S. stock index futures were steady on Tuesday, with those tracking the S&P 500 and the Nasdaq hovering around record highs, ahead of retail sales data and commentary from a number of Federal Reserve officials.
A
B
G
M
U
U
U

New highs as retail eyed, Europe calms

MORNING BID AMERICAS-New highs as retail eyed, Europe calms A look at the day ahead in U.S. and global markets from Mike Dolan Tech-led Wall Street stocks have sailed to new records again this week, with Tuesday expected to see retail sales return to growth and as nervy European markets calmed for a second day. The relentless outperformance of U.S.
A
A
M
N
U
J
U
U

Canada - June 18

PRESS DIGEST-Canada - June 18 June 18 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL **Canadian autonomous-vehicle company Waabi has raised $200 million in a Series B funding round, led by existing investors Uber Technologies UBER.N and Khosla Ventures, to support the rollout of its fully autonomous trucks next year.
A
A
S
U

U.S. Aerovate Therapeutics, Boeing, Wingstop

U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop June 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Aerovate Therapeutics, Boeing and Wingstop, on Tuesday. HIGHLIGHTS * Aerovate Therapeutics Inc AVTE.O : TD Cowen cuts to hold from buy * Boeing BA.N : RBC cuts target price to $210 from $215 * Mirum Pharmaceuticals Inc MIRM.O : Evercore ISI raises target price to $62 from $53 * Transdigm Group Inc TDG
A
B
U
T

Motor racing-Brad Pitt's F1 movie set for release in June 2025

Motor racing-Brad Pitt's F1 movie set for release in June 2025 June 18 (Reuters) - Brad Pitt's as-yet unnamed Formula One movie will be released globally on June 25 next year, with a North American debut two days later, F1 and Apple Original Films announced on Tuesday. The film is being made with the cooperation of teams and drivers and directed by Joseph Kosinski, whose 'Top Gun: Maverick' grossed $1.49 billion worldwide, with Jerry Bruckheimer as producer.
A
F
N

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.